STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
11.35% 11.33% 10.41% 10.10%

+8 more TTM periods

Piotroski F-Score
8 9 9 8
ROA
7.62% 7.49% 6.87% 6.67%
ROIC
8.27% 7.92% 7.24% 7.07%
Return on Tangible Assets
24.14% 22.94% 20.24% 20.81%
Average Days of Receivables
61.25 67.20 62.04 60.63
Free Cash Flow per Share
9.59 10.01 9.54 9.86
Free Cash Flow
936.00 982.90 936.70 970.40
Capital Expenditures
(352.50) (358.50) (330.10) (331.00)
Other line items
Cash ROIC
9.75% 10.27% 9.87% 10.50%
Accounts Receivable Turnover
6.16 5.56 6.12 6.10
Accounts Payable Turnover
10.40 10.68 12.45 11.68
Inventory Turnover
4.96 5.46 4.92 4.72
Average Days of Payables
37.44 37.37 31.94 35.49
Days of Inventory on Hand
77.48 69.68 75.46 75.65
Tax Rate
(0.26) (0.25) (0.24) (0.24)
Research and Development Expense of Revenue
1.91% 1.90% 1.92% 1.92%
Selling, General and Administrative Expense of Revenue
23.58% 23.72% 23.84% 24.08%
Share Based Compensation of Revenue
1.04% 1.04% 1.01% 1.02%
Interest Coverage
18.84 18.15 15.94 14.53
Operating CF/Net income
1.60 1.71 1.79 1.89
Depreciation/Fixed assets
0.23 0.23 0.23 0.23
Capex/Depreciation
(0.72) (0.74) (0.68) (0.68)
Revenue per Share
61.86 60.45 59.35 57.95
Operating CF per Share
13.20 13.66 12.90 13.23
Capex per Share
(3.61) (3.65) (3.36) (3.36)
Capex to Sales
0.06 0.06 0.06 0.06

Fold the line items

Columns are period end dates